Crossmark

Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis

Crossref DOI link: https://doi.org/10.1016/j.mtbio.2020.100055

Published Print: 2020-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Wang, G.Y.

Rayner, S.L.

Chung, R. https://orcid.org/0000-0002-9286-947X
Shi, B.Y.

Liang, X.J. https://orcid.org/0000-0001-7997-1026
Funding

Funding for this research was provided by:

Macquarie University (NSFC 31640027)

ARC dementia Career Development Research Fellowship (APP 1111611)

ARC dementia Career Development Research Fellowship (U1604177)

National Natural Science Foundation of China

National Health and Medical Research Council (GNT1166024)

National Key Technologies R&D program (2018YFA0209800)

Macquarie University
License Information

Text and Data Mining valid from 2020-03-01

Text and Data Mining valid from 2020-03-01

Version of Record valid from 2020-04-27
More Information

This article is maintained by: Elsevier

Article Title: Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis

Journal Title: Materials Today Bio

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.mtbio.2020.100055

Content Type: article

Copyright: © 2020 The Authors. Published by Elsevier Ltd.